Health Care & Life Sciences » Pharmaceuticals | Beximco Pharmaceuticals Ltd.

Beximco Pharmaceuticals Ltd. GDR | Income Statement

Fiscal year is July-June. All values BDT Millions.
2012
2013
2014
2016
2017
2018
Sales/Revenue
9,289
10,491
11,207
13,356
15,509
17,717
Cost of Goods Sold (COGS) incl. D&A
5,033
5,585
6,046
7,111
8,330
9,501
Gross Income
4,256
4,906
5,161
6,245
7,179
8,215
SG&A Expense
2,144
2,582
2,743
3,273
3,875
4,358
EBIT
2,112
2,324
2,418
2,972
3,304
3,858
Non Operating Income/Expense
72
188
146
182
134
96
Interest Expense
568
555
653
621
449
455
Pretax Income
1,910
2,094
2,110
2,439
2,891
3,361
Income Tax
590
689
581
473
665
829
Consolidated Net Income
1,319
1,405
1,528
1,966
2,227
2,533
Net Income
1,319
1,405
1,528
1,966
2,227
2,537
Net Income After Extraordinaries
1,319
1,405
1,528
1,966
2,227
2,537
Net Income Available to Common
1,319
1,405
1,528
1,966
2,227
2,537
EPS (Basic)
3.25
3.46
3.76
5.09
5.49
6.25
Basic Shares Outstanding
406
406
406
386
406
406
EPS (Diluted)
3.25
3.46
3.77
5.09
5.49
6.25
Diluted Shares Outstanding
406
406
406
386
406
406
EBITDA
2,702
2,914
3,183
3,735
4,086
4,704
Non-Operating Interest Income
437
512
490
270
161
55
Equity in Affiliates (Pretax)
-
-
-
-
11
-

About Beximco Pharmaceuticals

View Profile
Address
19 Dhanmondi R/A
Dhaka DA 1205
Bangladesh
Employees -
Website http://www.beximco-pharma.com
Updated 07/08/2019
Beximco Pharmaceuticals Ltd. is engaged in manufacturing and marketing of generic pharmaceuticals formulation products including life saving intravenous fluids, therapeutic nutrition products and active pharmaceutical ingredients. Its products include analgesics, anti-infectives, cardiovascular, intravenous fluids, central nervous system, gastrointestinal, respiratory, dermatology, muscloskeletal and ophthalmics. The company was founded in 1976 and is headquartered in Dhaka, Bangladesh.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.